Canada Markets closed

Emerald Health Therapeutics, Inc. (EMHTF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0405+0.0144 (+55.17%)
At close: 03:42PM EST
Currency in USD

Valuation Measures4

Market Cap (intraday) N/A
Enterprise Value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.63
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 30.0681
52 Week Low 30.0200
50-Day Moving Average 30.0321
200-Day Moving Average 30.0351

Share Statistics

Avg Vol (3 month) 389.24k
Avg Vol (10 day) 3166.5k
Shares Outstanding 5213.47M
Implied Shares Outstanding 6N/A
Float 8209.24M
% Held by Insiders 11.74%
% Held by Institutions 10.00%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in CAD.

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Jun 29, 2022


Profit Margin 0.00%
Operating Margin (ttm)-248.34%

Management Effectiveness

Return on Assets (ttm)-21.83%
Return on Equity (ttm)-66.58%

Income Statement

Revenue (ttm)7.13M
Revenue Per Share (ttm)0.03
Quarterly Revenue Growth (yoy)-72.60%
Gross Profit (ttm)-6.45M
EBITDA -17.12M
Net Income Avi to Common (ttm)-28.18M
Diluted EPS (ttm)-0.5670
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)15.52M
Total Cash Per Share (mrq)0.07
Total Debt (mrq)260k
Total Debt/Equity (mrq)0.93
Current Ratio (mrq)2.98
Book Value Per Share (mrq)0.40

Cash Flow Statement

Operating Cash Flow (ttm)-9.68M
Levered Free Cash Flow (ttm)516.12k